11 Best AI Stocks to Buy According to Hedge Funds

8. Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)

Number of Hedge Fund Holders: 19

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks to buy according to hedge funds. Earlier on June 6, a significant advancement in drug discovery was announced with the open-source release of Boltz-2, which is a biomolecular foundation model developed through a collaboration between researchers at the Massachusetts Institute of Technology (or MIT) Computer Science and Artificial Intelligence Lab (or CSAIL) and Jameel Clinic, and the TechBio company Recursion.

Boltz-2 is an AI model that combines the prediction of complex biomolecular structures with binding affinity prediction. It’s a substantial improvement on previous models like AlphaFold3 and its predecessor, called Boltz-1. The model was trained and validated using Recursion’s NVIDIA supercomputer, called BioHive-2, that features 504 NVIDIA H100 GPUs and achieves ~2 exaflops of AI performance.

Boltz-2 achieves accuracy comparable to physics-based Free Energy Perturbation/FEP calculations, which is an industry-standard method for predicting how strongly molecules bind, but at speeds up to 1000 times faster. This increase in speed and efficiency reduces the cost and time involved in large-scale virtual screening, thereby addressing a bottleneck in the early stages of small-molecule drug discovery.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company that integrates technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the US.